Latest Biotech News

Dublin-based biotech Aerska recently secured $21 million in a financing round led by Age1, Backed VC, and Speedinvest to advance its RNA interference (RNAi) therapeutics. The company focuses on...

AstraZeneca and Daiichi Sankyo announced positive data from a registrational Phase 3 study of Datroway, a next-generation drug succeeding Enhertu, in triple-negative breast cancer (TNBC). This...

Trogenix has raised $95 million in a Series A financing round to push forward its innovative "Trojan horse" modality aimed at treating brain cancer, starting with glioblastoma. The capital...

The U.S. Food and Drug Administration (FDA) announced a pilot program to expedite regulatory review of generic drugs that are both tested and manufactured domestically with U.S.-sourced active...

Ignota Labs has acquired the clinical pipeline of Kronos Bio following setbacks that led to Kronos’s departure from public markets. This acquisition underlines Ignota's innovative approach to...

Pfizer secured a three-year exemption from planned 100% tariffs under a deal with the Trump administration, agreeing to expand U.S. manufacturing and implement 'most favored nation' Medicaid...

Emerging data present T cell engagers as a promising biologic class capable of inducing 'immune reset' for autoimmune diseases by selectively eliminating autoreactive B cells and plasma cells....

Researchers have introduced DeepMice, an innovative protein-ligand molecular docking model employing advanced multilevel mapping to enhance accuracy and efficiency in drug discovery. This...

Regencell Bioscience Holdings (NASDAQ: RGC) experienced an extraordinary stock price increase exceeding 64,000% during a speculative frenzy in mid-2025. The Hong Kong-based biotech focuses on...

Researchers demonstrated chip-fiber-chip quantum teleportation within a star-topology quantum network, advancing the development of scalable quantum communication infrastructure. This breakthrough...

Researchers have developed a novel physics-based algorithm that leverages artificial intelligence to design biomolecules with tailor-made properties. This development marks a significant advance...

Emerging biologics called T cell engagers are poised to transform autoimmune disease treatment by enabling an 'immune reset.' Unlike conventional broad immunosuppression, these agents directly...

The FDA has initiated a pilot program to accelerate regulatory reviews of generic drugs that are tested and manufactured entirely in the United States using domestically sourced active...

Trogenix Biosciences has closed a $95 million Series A financing round to propel its novel brain cancer treatment technology toward clinical evaluation. The company's lead program leverages a...

Pfizer saw its shares jump 14% over two trading days following its agreement with the Trump administration granting a three-year tariff exemption in exchange for increased U.S. drug manufacturing...

Regencell Bioscience Holdings experienced an unprecedented stock price surge of 64,000% within a week, fueled by retail mania and a 38-for-1 stock split that dramatically increased liquidity....

Researchers have unveiled EDG-PPIS, an innovative equivariant and dual-scale graph neural network framework, significantly enhancing prediction accuracy of protein-protein interaction sites. This...

At the European Association of Nuclear Medicine Congress, researchers revealed that metabolically active visceral fat contributes to more aggressive endometrial cancer phenotypes. This finding...

Recent comprehensive mapping highlights the global clinical advancement of Natural Killer (NK) cell therapies in treating solid tumors. These immunotherapies, designed to harness innate immune...

The newly developed DeepMice model represents a revolutionary computational approach to protein-ligand molecular docking, employing advanced multilevel mapping techniques. This novel framework...